MARKER THERAPEUTICS, INC. Increase Decrease In Operating Lease Liability
MARKER THERAPEUTICS, INC. (MRKR) reported Increase Decrease In Operating Lease Liability of -$127.80 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2023-05-15
- MARKER THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2023-03-31 was -$127.80K.
- MARKER THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2022-12-31 was -$99.90K.
- MARKER THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2022-09-30 was -$113.62K.
- MARKER THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2022-06-30 was -$151.75K.
- MARKER THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2022 was -$513.89K.
- MARKER THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2021 was -$388.79K.
- MARKER THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2020 was -$173.27K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2023-03-31 | -$127.80K 10-Q · filed 2023-05-15 | -$227.71K derived: sum of 2 quarters · filed 2023-05-15 | -$341.33K derived: sum of 3 quarters · filed 2023-05-15 | -$493.08K derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-12-31 | -$99.90K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$213.52K derived: sum of 2 quarters · filed 2023-03-22 | -$365.28K derived: sum of 3 quarters · filed 2023-03-22 | -$513.89K 10-K · filed 2023-03-22 |
| 2022-09-30 | -$113.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$265.37K derived: sum of 2 quarters · filed 2022-11-10 | -$413.99K 10-Q · filed 2022-11-10 | -$558.03K derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-06-30 | -$151.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$300.37K 10-Q · filed 2022-08-11 | -$444.41K derived: sum of 3 quarters · filed 2023-05-15 | -$558.66K derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-03-31 | -$148.61K 10-Q · filed 2023-05-15 | -$292.65K derived: sum of 2 quarters · filed 2023-05-15 | -$406.90K derived: sum of 3 quarters · filed 2023-05-15 | -$473.08K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$144.04K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$258.29K derived: sum of 2 quarters · filed 2023-03-22 | -$324.46K derived: sum of 3 quarters · filed 2023-03-22 | -$388.79K 10-K · filed 2023-03-22 |
| 2021-09-30 | -$114.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$180.42K derived: sum of 2 quarters · filed 2022-11-10 | -$244.75K 10-Q · filed 2022-11-10 | -$251.30K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$66.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$130.50K 10-Q · filed 2022-08-11 | -$137.05K derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$64.33K 10-Q · filed 2022-05-13 | -$70.87K derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2020-12-31 | -$6.54K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$173.27K 10-K · filed 2022-03-17 | ||
| 2020-09-30 | -$166.72K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |